Brooks Laboratories Ltd., incorporated in the year 2002, is a Small Cap company (having a market cap of Rs 419.92 Crore) operating in Pharmaceuticals sector.
Brooks Laboratories Ltd. key Products/Revenue Segments include Drugs, Export Incentives, Other Operating Revenue for the year ending 31-Mar-2024.
For the quarter ended 30-09-2024, the company has reported a Consolidated Total Income of Rs 20.99 Crore, up 16.60 % from last quarter Total Income of Rs 18.00 Crore and down 14.00 % from last year same quarter Total Income of Rs 24.41 Crore. Company has reported net profit after tax of Rs .96 Crore in latest quarter.
Brooks Laboratories Ltd. key Products/Revenue Segments include Drugs, Export Incentives, Other Operating Revenue for the year ending 31-Mar-2024.
For the quarter ended 30-09-2024, the company has reported a Consolidated Total Income of Rs 20.99 Crore, up 16.60 % from last quarter Total Income of Rs 18.00 Crore and down 14.00 % from last year same quarter Total Income of Rs 24.41 Crore. Company has reported net profit after tax of Rs .96 Crore in latest quarter.
Trade closed: target reached
target done 187
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.